Encompass Health Stock Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health or view top-rated stocks.

9 Wall Street analysts have issued twelve-month price objectives for Encompass Health's stock. Their EHC stock forecasts range from $70.00 to $98.00. On average, they predict Encompass Health's share price to reach $79.56 in the next twelve months. This suggests a possible upside of 41.2% from the stock's current price.
View analysts' price targets for Encompass Health or view top-rated stocks among Wall Street analysts.

Encompass Health's stock was trading at $65.26 at the beginning of the year. Since then, EHC shares have decreased by 13.6% and is now trading at $56.36.
View the best growth stocks for 2022 here.

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Encompass Health.

Encompass Health Co. (NYSE:EHC) issued its earnings results on Wednesday, April, 27th. The company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.32 billion. Encompass Health had a trailing twelve-month return on equity of 17.99% and a net margin of 7.51%. The company's revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.05 earnings per share.
View Encompass Health's earnings history.

Encompass Health announced a quarterly dividend on Thursday, May 5th. Stockholders of record on Wednesday, July 13th will be paid a dividend of $0.28 per share on Wednesday, July 20th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.99%. The ex-dividend date of this dividend is Tuesday, July 12th.
View Encompass Health's dividend history.

Encompass Health(NYSE:EHC) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.98%. The dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

Encompass Health issued an update on its FY 2022 earnings guidance on Tuesday, June, 28th. The company provided earnings per share (EPS) guidance of $3.76-$4.05 for the period, compared to the consensus estimate of $4.12. The company issued revenue guidance of $5.33 billion-$5.42 billion, compared to the consensus revenue estimate of $5.46 billion.

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

Some companies that are related to Encompass Health include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Acadia Healthcare (ACHC), Tenet Healthcare (THC), The Ensign Group (ENSG), Petco Health and Wellness (WOOF), Select Medical (SEM), U.S. Physical Therapy (USPH), National HealthCare (NHC), Brookdale Senior Living (BKD), Community Health Systems (CYH) and Five Star Senior Living (FVE).
View all of EHC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Encompass Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.68%), Vanguard Group Inc. (9.40%), Wellington Management Group LLP (8.87%), Baupost Group LLC MA (3.01%), Jana Partners LLC (2.83%) and State Street Corp (2.74%). Company insiders that own Encompass Health stock include Andrew L Price, Donald L Correll, Elissa Joy Charbonneau, Kevin J O'connor, Mark J Tarr and Terrance Williams.
View institutional ownership trends for Encompass Health.

EHC stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, TimesSquare Capital Management LLC, Royal Bank of Canada, Goldman Sachs Group Inc., Invesco Ltd., Prosight Management LP, Jana Partners LLC, and UBS Group AG. Company insiders that have sold Encompass Health company stock in the last two years include Andrew L Price, and Elissa Joy Charbonneau.
View insider buying and selling activity for Encompass Health or view top insider-selling stocks.

EHC stock was purchased by a variety of institutional investors in the last quarter, including Baupost Group LLC MA, Empyrean Capital Partners LP, Paradice Investment Management LLC, Glenview Capital Management LLC, Bank of New York Mellon Corp, Kempen Capital Management N.V., Dimensional Fund Advisors LP, and Renaissance Technologies LLC. Company insiders that have bought Encompass Health stock in the last two years include Kevin J O'connor, and Terrance Williams.
View insider buying and selling activity for Encompass Health or or view top insider-buying stocks.

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EHC stock can currently be purchased for approximately $56.36.

Encompass Health (NYSE:EHC) has a market capitalization of $5.62 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.909990 on an earnings per share basis.

Encompass Health employs 43,400 workers across the globe.

Encompass Health was founded in 1984.

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for Encompass Health is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719.